104 related articles for article (PubMed ID: 21050886)
1. Pharmacokinetic properties and metabolism of a new potent antimalarial N-alkylamidine compound, M64, and its corresponding bioprecursors.
Margout D; Gattacceca F; Moarbess G; Wein S; Tran van Ba C; Le Pape S; Berger O; Escale R; Vial HJ; Bressolle FM
Eur J Pharm Sci; 2011 Jan; 42(1-2):81-90. PubMed ID: 21050886
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimalarial activity of new 1,12-bis(N,N'-acetamidinyl)dodecane derivatives.
Ouattara M; Wein S; Calas M; Hoang YV; Vial H; Escale R
Bioorg Med Chem Lett; 2007 Feb; 17(3):593-6. PubMed ID: 17123818
[TBL] [Abstract][Full Text] [Related]
3. In vitro biotransformation, in vivo efficacy and pharmacokinetics of antimalarial chalcones.
Gutteridge CE; Thota DS; Curtis SM; Kozar MP; Li Q; Xie L; Zhang J; Melendez V; Asher CO; Luong TT; Gerena L; Nichols DA; Montip G
Pharmacology; 2011; 87(1-2):96-104. PubMed ID: 21282967
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of bis-alkylamidoxime O-alkylsulfonates as orally available antimalarials.
Degardin M; Wein S; Gouni S; Tran Van Ba C; Duckert JF; Durand T; Escale R; Vial H; Vo-Hoang Y
ChemMedChem; 2012 Jun; 7(6):991-1001. PubMed ID: 22544438
[TBL] [Abstract][Full Text] [Related]
5. Rapid resolution liquid chromatography-mass spectrometry determination of SAR97276 in monkey matrices. Pharmacokinetics in rhesus monkey infected by Plasmodium cynomolgi.
Margout D; Bontemps N; Kocken CH; Vial HJ; Bressolle FM
J Pharm Biomed Anal; 2009 Jul; 49(5):1266-71. PubMed ID: 19303732
[TBL] [Abstract][Full Text] [Related]
6. In vitro metabolism of phenoxypropoxybiguanide analogues in human liver microsomes to potent antimalarial dihydrotriazines.
Shearer TW; Kozar MP; O'Neil MT; Smith PL; Schiehser GA; Jacobus DP; Diaz DS; Yang YS; Milhous WK; Skillman DR
J Med Chem; 2005 Apr; 48(8):2805-13. PubMed ID: 15828818
[TBL] [Abstract][Full Text] [Related]
7. N-substituted bis-C-alkyloxadiazolones as dual effectors: efficient intermediates to amidoximes or amidines and prodrug candidates of potent antimalarials.
Degardin M; Wein S; Durand T; Escale R; Vial H; Vo-Hoang Y
Bioorg Med Chem Lett; 2009 Sep; 19(17):5233-6. PubMed ID: 19643611
[TBL] [Abstract][Full Text] [Related]
8. Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarials.
Caldarelli SA; Boisbrun M; Alarcon K; Hamzé A; Ouattara M; Salom-Roig X; Maynadier M; Wein S; Peyrottes S; Pellet A; Calas M; Vial H
Bioorg Med Chem Lett; 2010 Jul; 20(13):3953-6. PubMed ID: 20605450
[TBL] [Abstract][Full Text] [Related]
9. A liquid chromatography-mass spectrometry assay for simultaneous determination of two antimalarial thiazolium compounds in human and rat matrices.
Taudon N; Margout D; Calas M; Kezutyte T; Vial HJ; Bressolle FM
J Pharm Biomed Anal; 2008 Nov; 48(3):1001-5. PubMed ID: 18678456
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of amidoxime derivatives as prodrug candidates of potent bis-cationic antimalarials.
Berger O; Ortial S; Wein S; Denoyelle S; Bressolle F; Durand T; Escale R; Vial HJ; Vo-Hoang Y
Bioorg Med Chem Lett; 2019 Aug; 29(16):2203-2207. PubMed ID: 31255483
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of amidoxime derivatives for orally potent C-alkylamidine-based antimalarial agents.
Ouattara M; Wein S; Denoyelle S; Ortial S; Durand T; Escale R; Vial H; Vo-Hoang Y
Bioorg Med Chem Lett; 2009 Feb; 19(3):624-6. PubMed ID: 19124242
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation and pharmacokinetics of the antiplasmodial naphthylisoquinoline alkaloid dioncophylline A.
Sieber M; Dekant W; Faber JH; Bringmann G
Xenobiotica; 2006 Sep; 36(9):750-62. PubMed ID: 16971341
[TBL] [Abstract][Full Text] [Related]
13. Conformationally restrained aromatic analogues of fosmidomycin and FR900098.
Kurz T; Schlüter K; Pein M; Behrendt C; Bergmann B; Walter RD
Arch Pharm (Weinheim); 2007 Jul; 340(7):339-44. PubMed ID: 17611943
[TBL] [Abstract][Full Text] [Related]
14. Development of the first oral bioprecursors of bis-alkylguanidine antimalarial drugs.
Degardin M; Wein S; Duckert JF; Maynadier M; Guy A; Durand T; Escale R; Vial H; Vo-Hoang Y
ChemMedChem; 2014 Feb; 9(2):300-4. PubMed ID: 24403182
[TBL] [Abstract][Full Text] [Related]
15. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial and antiplasmodial activities of norneolignans. Syntheses and SAR.
Skytte DM; Nielsen SF; Chen M; Zhai L; Olsen CE; Christensen SB
J Med Chem; 2006 Jan; 49(1):436-40. PubMed ID: 16392829
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of L-valine-amidoximeesters as double prodrugs of amidines.
Kotthaus J; Hungeling H; Reeh C; Kotthaus J; Schade D; Wein S; Wolffram S; Clement B
Bioorg Med Chem; 2011 Mar; 19(6):1907-14. PubMed ID: 21345682
[TBL] [Abstract][Full Text] [Related]
18. Mono- and bis-thiazolium salts have potent antimalarial activity.
Hamzé A; Rubi E; Arnal P; Boisbrun M; Carcel C; Salom-Roig X; Maynadier M; Wein S; Vial H; Calas M
J Med Chem; 2005 May; 48(10):3639-43. PubMed ID: 15887971
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.
Altenkämper M; Bechem B; Perruchon J; Heinrich S; Mädel A; Ortmann R; Dahse HM; Freunscht E; Wang Y; Rath J; Stich A; Hitzler M; Chiba P; Lanzer M; Schlitzer M
Bioorg Med Chem; 2009 Nov; 17(22):7690-7. PubMed ID: 19819706
[TBL] [Abstract][Full Text] [Related]
20. New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton.
Opsenica I; Opsenica D; Lanteri CA; Anova L; Milhous WK; Smith KS; Solaja BA
J Med Chem; 2008 Oct; 51(19):6216-9. PubMed ID: 18774792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
